Interplay between the SAFE and the sphingolipid pathway for cardioprotection.

Saved in:
Bibliographic Details
Title: Interplay between the SAFE and the sphingolipid pathway for cardioprotection.
Authors: Cour M; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Pedretti S; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Nduhirabandi F; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Hacking D; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Frias MA; Division of Laboratory Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland., Hausenloy DJ; The Hatter Cardiovascular Institute, University College London, London, UK., Lecour S; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address: Sandrine.lecour@uct.ac.za.
Source: Life sciences [Life Sci] 2024 Dec 01; Vol. 358, pp. 123145. Date of Electronic Publication: 2024 Oct 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0631 (Electronic) Linking ISSN: 00243205 NLM ISO Abbreviation: Life Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0631
DOI:10.1016/j.lfs.2024.123145